RAT MONOCLONAL-ANTIBODIES FOR BONE-MARROW TRANSPLANTATION (BMT) - THE CAMPATH SERIES

RAT MONOCLONAL-ANTIBODIES FOR BONE-MARROW TRANSPLANTATION (BMT) - THE CAMPATH SERIES

Bibliographic Details
Main Authors:	Waldmann, H, Hale, G, Cobbold, S, Clark, M, Tighe, H, Bindon, C
Format:	Journal article
Published:	1985

Similar Items

Rat monoclonal antibodies for bone marrow transplantation--the CAMPATH series.
by: Waldmann, H, et al.
Published: (1985)

CAMPATH-1 monoclonal antibodies in bone marrow transplantation.
by: Hale, G, et al.
Published: (1994)

RAT MONOCLONAL-ANTIBODIES TO PREVENT G-VS-H AND H-VS-G REACTIONS IN BONE-MARROW TRANSPLANTATION
by: Waldmann, H, et al.
Published: (1986)

Availability of Campath-1 antibodies for bone marrow transplantation.
by: Hale, G, et al.
Published: (1995)

T cell depletion with CAMPATH-1 in allogeneic bone marrow transplantation.
by: Hale, G, et al.
Published: (1988)

Leukaemic relapse after Campath 1-treated bone-marrow transplantation for leukaemia.
by: Waldmann, H, et al.
Published: (1987)

RESULTS OF T-CELL DEPLETION WITH CAMPATH-1 IN BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC GRANULOCYTIC-LEUKEMIA (CGL)
by: Apperley, J, et al.
Published: (1985)

Reactivity of rat monoclonal antibody CAMPATH-1 with human leukaemia cells and its possible application for autologous bone marrow transplantation.
by: Hale, G, et al.
Published: (1985)

Anti-globulin responses to rat and humanized CAMPATH-1 monoclonal antibody used to treat transplant rejection.
by: Rebello, P, et al.
Published: (1999)

Specificity of monoclonal antibody Campath-1.
by: Hale, G, et al.
Published: (1988)

ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA USING CAMPATH-1 MONOCLONAL-ANTIBODIES AND POSTTRANSPLANT ALLOIMMUNIZATION WITH DONOR LYMPHOCYTES
by: Naparstek, E, et al.
Published: (1993)

EFFECTS OF MONOCLONAL-ANTIBODIES OF THE CAMPATH SERIES INVIVO - REQUIREMENTS FOR EFFECTIVE ANTIBODY THERAPY
by: Dyer, M, et al.
Published: (1988)

MONOCLONAL-ANTIBODIES FOR CONDITIONING PRIOR TO MARROW TRANSPLANTATION
by: Hale, G, et al.
Published: (1989)

Engraftment of marrow allografts treated with Campath-1 monoclonal antibodies.
by: Naparstek, E, et al.
Published: (1999)

CAMPATH-1 antibodies in stem-cell transplantation.
by: Hale, G, et al.
Published: (2001)

Reversal of allograft rejection using the monoclonal antibody, Campath-1G.
by: Friend, P, et al.
Published: (1991)

Monoclonals and marrow transplants.
by: Waldmann, H, et al.
Published: (1986)

Successful haploidentical mismatched bone marrow transplantation in severe combined immunodeficiency: T cell removal using CAMPATH-I monoclonal antibody and E-rosetting.
by: Morgan, G, et al.
Published: (1986)

Delayed allograft rejection in primates treated with anti-IL-2 receptor monoclonal antibody Campath-6.
by: Tighe, H, et al.
Published: (1988)

Pilot study of CAMPATH-1, a rat monoclonal antibody that fixes human complement, as an immunosuppressant in organ transplantation.
by: Hale, G, et al.
Published: (1986)

INTERACTION OF MONOCLONAL-ANTIBODIES WITH THE IMMUNE-SYSTEM
by: Clark, M, et al.
Published: (1986)

COMBINED USE OF CAMPATH-1G IN-VIVO AND IN THE BAG IN ALLOGENEIC BONE-MARROW TRANSPLANTATION
by: Fibbe, W, et al.
Published: (1993)

MONOCLONAL-ANTIBODIES CAN BE USED TO CONTROL BOTH GVHD AND REJECTION IN MOUSE MODELS OF BONE-MARROW TRANSPLANTATION
by: Cobbold, S, et al.
Published: (1985)

Ex vivo T-cell depletion with the monoclonal antibody Campath-1 plus human complement effectively prevents acute graft-versus-host disease in allogeneic bone marrow transplantation.
by: Heit, W, et al.
Published: (1986)

CAMPATH-1 monoclonal antibody therapy in severe refractory autoimmune thrombocytopenic purpura.
by: Lim, S, et al.
Published: (1993)

HAPLOIDENTICAL BONE-MARROW TRANSPLANTATION - INVIVO CONDITIONING WITH MONOCLONAL-ANTIBODIES
by: Fasth, A, et al.
Published: (1988)

Monoclonal antibody therapy of diffuse cutaneous scleroderma with CAMPATH-1H.
by: Isaacs, J, et al.
Published: (1996)

Advantages of rat monoclonal antibodies.
by: Clark, M, et al.
Published: (1983)

Appropriate targets for monoclonal antibodies in the induction of transplantation tolerance.
by: Waldmann, H, et al.
Published: (2001)

REMISSION INDUCTION IN PATIENTS WITH LYMPHOID MALIGNANCIES USING UNCONJUGATED CAMPATH-1 MONOCLONAL-ANTIBODIES
by: Dyer, M, et al.
Published: (1990)

Monoclonal antibodies for immunosuppression.
by: Waldmann, H, et al.
Published: (1988)

Monoclonal antibodies for the induction of transplantation tolerance.
by: Waldmann, H, et al.
Published: (1993)

Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody CAMPATH-1H.
by: Hale, G, et al.
Published: (1988)

Monoclonal antibody therapy of chronic intraocular inflammation using Campath-1H.
by: Isaacs, J, et al.
Published: (1995)

The CAMPATH-1 antigen (CDw52).
by: Hale, G, et al.
Published: (1990)

Risks of developing Epstein-Barr virus-related lymphoproliferative disorders after T-cell-depleted marrow transplants. CAMPATH Users.
by: Hale, G, et al.
Published: (1998)

Therapeutic potential of monoclonal antibodies to the leucocyte common antigen.
by: Bindon, C, et al.
Published: (1985)

Importance of antigen specificity for complement-mediated lysis by monoclonal antibodies.
by: Bindon, C, et al.
Published: (1988)

Impact on T-cell depletion and CD34+ cell recovery using humanised CD52 monoclonal antibody (CAMPATH-1H) in BM and PSBC collections; comparison with CAMPATH-1M and CAMPATH-1G.
by: Williams, R, et al.
Published: (2000)

Prevention of immune-mediated corneal graft destruction with the anti-lymphocyte monoclonal antibody, CAMPATH-1H.
by: Newman, D, et al.
Published: (1995)